{
  "pmid": "39787606",
  "topic": "sepsis_diagnosis_criteria",
  "pdf_path": "Annane_Sepsis_Corpus\\papers\\PMID_39787606\\paper.pdf",
  "sectionizer": "simple_pdfplumber",
  "sections": {
    "Abstract": "ORIGINAL ARTICLE Status of Sepsis Care in European Hospitals Results from an International Cross-Sectional Survey Christian S. Scheer1, Evangelos J. Giamarellos-Bourboulis2, Ricard Ferrer3, Evgeny A. Idelevich4,5, Djillali Annane6,7, Antonio Artigas8, Abdullah Tarik Aslan9, Gabriella Bottari10, Hjalmar R. Bouma11, Vladimir C (cid:1) ern (cid:3) y12,13, Renata Curi (cid:3) c Radivojevi (cid:3) c14, Konstantina Dakou15, Ken Dewitte16, Mohamed Elbahnasawy17, Matthias Gru € ndling1, Mohan Gurjar18, Johanna Ha € stbacka19,20, Miltiadis Kyprianou2, Said Laribi21, Annmarie Lassen22, Konstantin Lebedinskii23, Jan Ma (cid:3) ca24, Manu L. N. G. Malbrain25,26, Gianpaola Monti27, Marlies Ostermann28, Michael Osthoff29,30, Jose (cid:3) -Artur Paiva31, Michela Sabbatucci32, Jakub S (cid:3) miechowicz33, Mihai Gabriel S¸tefan34, Marcus Vollmer35, Natalija Vukovi (cid:3) c36, Kyriakos Zaragkoulias37,38, Konrad Reinhart39, Adam Linder40*, and Daniela Filipescu34,41*; for the European Sepsis Care Study Group Abstract managementwasstandardizedin57.3%ofEDs,45.2%ofwards, and70.7%ofICUs.TheimplementationofcomprehensiveQIIs Rationale:Earlydetection,standardizedtherapy,adequate wasassociatedwithincreasedscreening(EDs,133.3%;wards, infrastructure,andstrategiesforqualityimprovementshould 144.4%;ICUs,123.8%absolutedifference)andincreased constituteessentialcomponentsofeveryhospital’ssepsisplan. standardizedsepsismanagement(EDs,133.6%;wards,140.0%; Objectives:Toinvestigatetheextenttowhichrecommendations ICUs,117.7%absolutedifference)comparedwithhospitals fromthesepsisguidelinesareimplementedandtheavailabilityof withoutQIIs.Atotalof9.8%ofhospitalshadimplemented infrastructureforthecareofpatientswithsepsisinacute-care ongoingQIIs,and4.6%hadinvestedinsepsisprograms. hospitals. Conclusions: Thefindingsindicatethatthereisconsiderable",
    "Method": "Methods:Amultidisciplinarycross-sectionalquestionnairewasused roomforimprovementinalargenumberofmainlyEuropean toinvestigatesepsiscareinhospitals.Thisincludedtheuseofsepsis hospitals,particularlywithregardtoearlyidentification definitions,theimplementationofsepsisguidelinerecommendations, andstandardizedmanagementofsepsis,theavailabilityof diagnosticandtherapeuticinfrastructure,antibioticstewardship,and guidelines,diagnosticandtherapeuticinfrastructure,andthe qualityimprovementinitiatives(QIIs)inhospitals. implementationofQIIs.Furthereffortsarerequiredto implementamorecomprehensiveandappropriatequality MeasurementsandMainResults: Atotalof1,023hospitalsin ofcare. 69countrieswereincluded.Mostofthem,835(81.6%),werein Europe.Sepsisscreeningwasusedin54.2%ofemergency Keywords: sepsisscreening;sepsismanagement; standardofcare; departments(EDs),47.9%ofwards,and61.7%ofICUs.Sepsis qualityof care;sepsisprograms (ReceivedinoriginalformJune13,2024;acceptedinfinalformJanuary6,2025) ThisarticleisopenaccessanddistributedunderthetermsoftheCreativeCommonsAttributionNon-Commercial NoDerivativesLicense4.0. Forcommercialusageandreprints,pleasee-mailDianeGern(dgern@thoracic.org). *Theseauthorscontributedequallytothiswork. SupportedbytheEuropeanSepsisAllianceandaneducationalgrantfromBectonDickinsonSA.BectonDickinsonSAwasnotinvolvedinthestudy designorrecruitmentorinwriting,reviewing,orsubmissionofthemanuscript.Thisarticlerepresentstheviewsofthenamedauthorsonly. AuthorContributions:C.S.S.,K.R.,R.F.,E.A.I.,andM.Gru€ndlingcontributedtotheconceptualization.C.S.S.,D.F.,A.L.,R.F.,A.A.,S.L., M.Ostermann,M.Gru€ndling,E.J.G.-B.,E.A.I.,andK.R.contributedtothestudydesignandharmonizedthequestionnaire.D.F.,A.L.,E.A.I., A.T.A.,M.G.S¸.,K.L.,J.S.,M.Gru€ndling,andM.Ostermantranslatedandcheckedthesurvey.C.S.S.,M.K.,M.V.,andK.D.,analyzedthedata andproducedthefiguresandtables.C.S.S.wrotethefirstdraftofthemanuscript.C.S.S.,E.J.G.-B.,D.F.,A.L.,E.A.I.,M.Osterman,J.H.,K.R., M.L.N.G.M.,M.Gru€ndling,andR.F.revisedthearticle.R.F.,D.A.,A.A.,A.T.A.,G.B.,H.R.B.,V.C.,R.C.R.,K.D.,M.E.,M.Gru€ndling,M.Gurjar, J.H.,K.L.,J.M.,M.L.N.G.M.,G.M.,M.Osterman,M.Osthoff,J.A.P.,M.S.,J.S.,S.L.,M.G.S.,A.Lassen,N.V.andK.Z.contributedasnational coordinatorsorrepresentativesofscientificsocietiestosurveydissemination,wereresponsibleforhospitalrecruitment,andchecked participants.Allauthorscontributedtodatainterpretation,providedsubstantialfeedbackonthearticle,andapprovedthesubmittedversion. AmJRespirCritCareMedVol211,Iss4,pp587–599,Apr2025 Copyright©2025bytheAmericanThoracicSociety OriginallyPublishedinPressasDOI:10.1164/rccm.202406-1167OConJanuary9,2025 Internetaddress:www:atsjournals:org Scheer, Giamarellos-Bourboulis, Ferrer, et al.: Sepsis Care in Hospitals 587 ORIGINAL ARTICLE 1DepartmentofAnesthesiology,IntensiveCareMedicine,EmergencyMedicineandPainMedicine,UniversityMedicineGreifswald, Greifswald,Germany;2FourthDepartmentofInternalMedicine,NationalandKapodistrianUniversityofAthensMedicalSchool, Athens,Greece;3IntensiveCareDepartment,Valld’HebronUniversityHospital.SODIRResearchGroup,Valld’HebronResearch Institute.MedicineDepartment,AutonomousUniversityofBarcelona,Barcelona,Spain;4FriedrichLoefflerInstituteofMedical Microbiology,UniversityMedicineGreifswald,Greifswald,Germany;5InstituteofMedicalMicrobiology,UniversityHospitalMu€nster, Mu€nster,Germany;6ServicedeRe(cid:3)animation,Ho^pitalRaymondPoincare(cid:3),AssistancePublique—Ho^pitauxdeParis,Garches,France; 7Universite(cid:3)VersaillesSaint-Quentin,Versailles,France;8SabadellUniversityHospital,ResearchandInnovationInstituteParcTauli (I3PTCERCA),CIBERRespiratoryDiseases,AutonomousUniversityofBarcelona,Sabadell,Spain;9DepartmentofInternalMedicine, HacettepeUniversity,Ankara,Turkey;10PediatricIntensiveCareUnitChildrenHospitalBambinoGesu(cid:3),InstituteforHealthand Research,Rome,Italy;11DepartmentofInternalMedicine,ClinicalPharmacyandPharmacology,UniversityMedicalCenterGroningen, UniversityofGroningen,Groningen,TheNetherlands;12DepartmentofAnesthesiaandIntensiveCareMedicine,ThirdFacultyof Medicine,CharlesUniversityinPrague,Prague,CzechRepublic;13FacultyofSocialSciencesandHealthCare,Constantinethe PhilosopherUniversityinNitra,Nitra,Slovakia;14DepartmentofAnesthesiology,ResuscitationandIntensiveCare,ZagrebUniversity HospitalCentre,Zagreb,Croatia;15TheHellenicInstitutefortheStudyofSepsis,Athens,Greece;16EmergencyDepartment,Antwerp UniversityHospital,Antwerp,Belgium;17DepartmentofEmergencyMedicineandTraumatology,TantaUniversity,Tanta,Egypt; 18DepartmentofCriticalCareMedicine,SanjayGandhiPostgraduateInstituteofMedicalSciences,Lucknow,India;19Departmentof Perioperative,IntensiveCareandPainMedicine,UniversityofHelsinkiandHelsinkiUniversityHospital,Helsinki,Finland;20Department ofAnesthesiaandIntensiveCare,TampereUniversityHospital,WellbeingServicesCountyofPirkanmaaandTampereUniversity, Tampere,Finland;21EmergencyMedicineDepartment,ToursUniversity,SchoolofMedicineandToursUniversityHospital,Centre HospitalierUniversitairedeTours,Tours,France;22DepartmentofEmergencyMedicine,OdenseUniversityHospital,Odense,Denmark; 23FederalResearchandClinicalCenterofIntensiveCareMedicineandRehabilitology,North-WestStateMedicalUniversitynamed afterI.I.Mechnikov,St.Petersburg,Russia;24DepartmentofAnesthesiologyandIntensiveCareMedicine,FacultyofMedicine, UniversityHospitalOstravaandUniversityofOstrava,Ostrava,CzechRepublic;25FirstDepartmentofAnesthesiologyandIntensive Therapy,MedicalUniversityofLublin,Lublin,Poland;26MedicalDataManagement,Medaman,Geel,Belgium;27Anestesiae RianimazionedeiTrapiantiDipartimentoChirurgicoPolispecialisticoASST,GrandeOspedaleMetropolitanoNiguardaMilano,Milan, Italy;28DepartmentofCriticalCare,King’sCollegeLondon,Guy’sandSt.Thomas’Hospital,London,UnitedKingdom;29Divisionof InternalMedicine,UniversityHospitalBasel,Basel,Switzerland;30DepartmentsofBiomedicineandClinicalResearch,Universityof Basel,Basel,Switzerland;31IntensiveCareMedicineService,SaoJoaoLocalHealthUnit,FacultyofMedicine,UniversityofPorto, Porto,Portugal;32DepartmentofInfectiousDiseases,ItalianNationalInstituteofHealth,Rome,Italy;33ClinicalDepartmentof AnesthesiologyandIntensiveTherapy,WroclawMedicalUniversity,Wroclaw,Poland;34DepartmentofAnesthesiologyandIntensive Care,“Prof.Dr.CCIliescu”EmergencyInstituteforCardiovascularDiseases,Bucharest,Romania;35InstituteofBioinformatics, UniversityMedicineGreifswald,Greifswald,Germany;36ClinicforAnesthesiology,ReanimationandIntensiveCare,UniversityClinical CenterNi(cid:1)s,Nis,Serbia;37DepartmentofLaboratoryMedicine,SectionforMedicalMicrobiology,Nord-TrøndelagHospitalTrust, Levanger,Norway;38DepartmentofMedicalMicrobiology,St.Olav’sHospital,TrondheimUniversityHospital,Trondheim,Norway; 39DepartmentofAnesthesiologyandOperativeIntensiveCareMedicine,Charite(cid:3)UniversityMedicineBerlin,Berlin,Germany; 40DivisionofInfectionMedicine,DepartmentofClinicalSciencesLund,FacultyofMedicine,LundUniversity,Lund,Sweden;and 41UniversityofMedicineandPharmacyCarolDavila,Bucharest,Romania ORCIDIDs:0000-0001-6171-8874(C.S.S.);0000-0003-4713-3911(E.J.G.-B.);0000-0002-8489-0324(M.Gurjar);0000-0002-9771-0468(J.M.); 0000-0002-1816-5255(M.L.N.G.M.);0000-0001-9500-9080(M.Osterman). Theincidenceofsepsisishigh,withalmost ThisisrecognizedbytheseventhWorld statementoftheG7HealthMinistersinMay 49millionnewcasesand11milliondeaths HealthAssemblyresolutionon“Improving 2022tointensifyeffortstostrengthenearly worldwideperyear(1).International theprevention,diagnosis,andmanagement detection,diagnosis,andtherapyofsepsis guidelinesstronglyrecommendroutine ofsepsis”(Resolution70.7)in2017,which andtoboosttheimplementationofthe sepsisscreeninginacutelyillpatientsat encouraged“MemberStatestodefineand WorldHealthAssembly70.7Resolution(4). highriskandtheapplicationofstandard implementstandardsandestablished Onequestioniswhetherexistinghospital operatingproceduresforsepsistreatment guidelines,infrastructure,laboratory facilitiesarereadytoreachthesegoals.This whenindicated(2).Inrecentyears,therehas capacity,strategies,andtoolsforidentifying, wouldrequirethedeliverytostateauthorities beeninternationalrecognitionoftheneed reducingincidenceof,andmorbidityand arealmappingoftheexistingfacilities, forhospitalfacilitiestoimprovesepsiscare. mortalityduetosepsis”(3)andbythe includinginfrastructure,availablepersonnel, C.S.S.,E.J.G.-B.,A.L.,A.A.andD.F.arerepresentativesoftheEuropeanSepsisAlliance.E.J.G.-B.isarepresentativeoftheEuropeansShock Society.R.F.andM.OstermannarerepresentativesoftheEuropeanSocietyofIntensiveCareMedicine.C.S.S.,E.J.G.-B.,E.A.I.,A.T.A.,andM. OsthoffarerepresentativesoftheEuropeanSocietyofClinicalMicrobiologyandInfectiousDiseasesStudyGroupforBloodstreamInfections, EndocarditisandSepsis.G.B.isarepresentativeoftheEuropeanSocietyofPaediatricandNeonatalIntensiveCare.S.L.isarepresentativeof theEuropeanSocietyforEmergencyMedicine.M.L.N.G.M.isarepresentativeoftheInternationalFluidAcademy.M.Ostermannisa representativeoftheIntensiveCareSocietyUnitedKingdom.K.R.isarepresentativeoftheGlobalSepsisAlliance.D.F.isarepresentativeof theEuropeanSocietyofAnaesthesiologyandIntensiveCare. Availabilityofdataandmaterials:thedatausedforthisanalysiscanbemadeavailableuponreasonablerequestforaslongas5years.For furtherinformation,pleasecontactthecorrespondingauthor. CorrespondenceandrequestsforreprintsshouldbeaddressedtoChristianS.Scheer,M.D.,DepartmentofAnesthesiology,IntensiveCare Medicine,EmergencyMedicineandPainMedicine,UniversityMedicineGreifswald,Ferdinand-Sauerbruch-Strasse17475Greifswald,Germany. E-mail:christian.scheer@med.uni-greifswald.de. Thisarticlehasarelatededitorial. AdatasupplementforthisarticleisavailableviatheSupplementstabatthetopoftheonlinearticle. 588 American Journal of Respiratory and Critical Care Medicine Volume 211 Number 4 | April 2025 ORIGINAL ARTICLE separatesectionsfortheemergency scientificsocieties.Thenationalcoordinators At a Glance Commentary departments(EDs),wards,andICUs(see weretaskedtoinvitehospitalsintheir onlinesupplementforthefullsurvey). respectivecountriesinawaythatwasas ScientificKnowledgeonthe Themainfocusofinterestwastheuse representativeaspossible,takinginto Subject:There are few data on ofsepsisdefinitionsandtheimplementation accountthedistinctionbetweenteachingand the implementation of guideline ofSurvivingSepsiscampaignguidelines, nonteachinghospitals,aswellastertiaryand recommendations and infrastructure includingsepsisscreeningforearly nontertiaryhospitals.Participationwas for the care of patients with sepsis recognitionandstandardizedsepsis encouragedbycallsfromtheendorsing in hospitals, especially in Europe. management,includingstandardoperating scientificsocieties(seeonlinesupplementfor proceduresformanagementandquality furtherdetailsregardingtherecruitment WhatThisStudyAddstothe improvementprograms(2).Quality strategiesineachcountry).Participantsself- Field:This study investigated for improvementinitiatives(QIIs)areprograms registeredorwereregisteredbythenational the firsttimethe implementation of thatincludemeetings,casereviews, coordinators.Followinganinitialverification guideline recommendations and informationalmaterial,andpeerreviews ofthehospitalatwhichtheparticipantwas infrastructure for the careofpatients withtheaimtoimprovethequalityof employed,aninvitationemailwassenttothe withsepsis ina large sample of sepsiscare. individual,containingauniquelinktoenable mainlyEuropean hospitals. Asecondfocusofinterestwas web-basedparticipation.Topreventthe infrastructureandresourcesforthecare inclusionofredundantorduplicatedata,a ofpatientswithsepsis.Thisincludedthe singleauthorizedrepresentativefromeach andbundlesofsepsismanagementto presenceofmedicalemergencyteamsforthe hospitalwasinvitedtorespondtoallqueries. increaseawarenessofthenecessary identificationandevaluationofcriticallyill Intheeventthatthedesignatedindividual correctiveactions. patients,theavailabilityofimagingforthe wasunabletoaddressallqueries,other Theobjectiveofthisstudywasto detectionofthesourceofinfection,the investigatetheimplementationofsepsis personnelfromrelevantdepartments(e.g., accessibilityofmicrobiologicaldiagnostic guidelinerecommendationsandthe ED,inpatientwards,ICU,ormicrobiological services,andtheavailabilityofsurgical availabilityofinfrastructureforthecareof laboratory)wereconsultedandinvitedto proceduresforsourcecontrol.Theuseof patientswithsepsisinpivotalhospital fluidsforhemodynamicresuscitation,the respond.Thesurveywasconductedonline departmentsinEuropeandotherregions. usingthesurveysoftwareLamaPoll(platin implementationofantimicrobialguidelines Someoftheresultsofthisstudyhavebeen version;LamanoGmbHandCoKG),which orrecommendationsforantiinfective previouslyreportedintheformofabstracts meetstherequirementsoftheEuropean treatment,andtheestablishmentof orconferencecontributions(5–18).Some UnionGeneralDataProtectionRegulation antibioticstewardshipteamswerealso oftheresultsofthesestudieshavebeen identifiedasessentialtherapeuticand andiscertifiedbytheDeutschesInstitutfu€r previouslyreportedintheformofapreprint NormungISO27001standard. structuralfeatures. (Lancet,2023Aug15;http://dx.doi.org/10. Hospitalsweregroupedinfiveregions: ThesurveywasavailableinEnglish, 2139/ssrn.4538229). Northern,Eastern,Southern,andWestern German,Polish,Romanian,Russian,and Europeandtherestoftheworld(i.e.,not Turkish.Technicalandcontent-related Europe),includingAsia,Africa,andCentral Methods pretestingwasconductedbysteering andSouthAmericaaccordingtothe committeemembersandnational definitionofUnitedNationsM49standard TheEuropeanSepsisCareSurvey(ESCS) coordinators.Thestudyprotocolreceived regions(21).Becauseofthewell-known wasconductedtoinvestigatethecurrent ethicalapprovalfromtheethicscommitteeof differencesbetweenhospitalsintermsof statusofsepsiscareinhospitals.TheESCS UniversityMedicineGreifswald,Germany theirnumbersofbedsanddifferenttypes, wasaddressedtohealthcareprofessionals (BB124/21),wheredataarestoredand hospitalswereclassifiedaccordingtothe workingindifferenthospitalsettings,mostly processed.Inallothercountries,thestudy inEurope,andtriedtoinvestigatethe wasapprovedpernationallegislation.The numberofbedsavailable,differentiating implementationofbasicprinciplesofsepsis studycomplieswiththeEQUATOR between0–250beds,251–500beds,501–750 recognitionandmanagementinroutine (EnhancingtheQualityandTransparencyof beds,751–1,000beds,andmorethan1,000 clinicalpractice. HealthResearch)networkreporting beds.Additionally,hospitalsweregrouped guidelines,CHERRIES(Checklistfor accordingtotheirtype,basedonthe StudyDesign,Harmonization, ReportingResultsofInternetE-Surveys) classificationprovidedbytheparticipants. andPretesting (19),andCROSS(ChecklistforReportingof Thisresultedinthreemaincategories: TheESCS,across-sectionalquestionnaire, SurveyStudies)(20)andwasregisteredat universityortraininghospitals,generalor wasdesignedandharmonizedbya clinicaltrials.gov(identifierNCT05059808). communityhospitals,andindependent multiprofessionalsteeringcommitteeledby orprivatehospitals.Thesefindingsare theEuropeanSepsisAllianceandpeer- SamplingStrategy,Technical presentedinTableE6andFigureE7.General reviewedbythescientificcommitteesoffour Realization,andStatisticalAnalysis measuresandinfrastructurewereanalyzed Europeanprofessionalscientificsocieties TheESCSwasconductedbetweenAugust fortheentirehospital.Giventhedistinct (TableE1intheonlinesupplement).The 2021andJune2022.Thesteeringcommittee organizationalstructuresobservedinthe surveyincluded94questions,including oftheESCSinvitednationalcoordinators EDs,wards,andICUs,aseparateanalysis overarchingquestionsandconcerning from26countriesand8international wasperformedforeachoftheseunits. Scheer, Giamarellos-Bourboulis, Ferrer, et al.: Sepsis Care in Hospitals 589 ORIGINAL ARTICLE Withregardtosepsisscreeningand Todate,thereisapaucityofdataregarding Theresponsesrelatedtothewardswere standardizedsepsismanagement,we theoptimalratesorlevelsofstandardized primarilyfrommedicalandsurgicalwards, exploredtheimplementation(i.e.,yes/no) screeningandsepsismanagementinhospitals. andthestatementsrelevanttoICUs andspecifiedtheindividualcriteriausedfor Therefore,acomparativeanalysiswas stemmedprimarilyfrominterdisciplinary recognitionandmeasuresfortreatment. conductedbetweenhospitalswithhospital- ICUs(TablesE8andE9). AsrecommendedintheSurvivingSepsis wideQIIsacrosstheED,allwards,andICUs campaignguidelines,QIIsandprograms andthosewithineachoftheregions.The UseofSepsisDefinitions wereanalyzedintermsofimplementation, performancegapbetweenthetwogroupswas Mosthospitals(45.4%;95%CI, scope,andfunding.Intheareaofessential calculatedastheabsolutedifference. 42.3%–48.5%)reportedusingtheSepsis-3 infrastructure,weinvestigatedwhether: definition(Table1).TheSepsis-3criteria 1)microbiologicallaboratorieswereableto wereusedmoreofteninNorthernEurope incubateandanalyzebloodculturesand Results (48.0%;95%CI,37.9%–58.2%)andSouthern reporttheresults,2)imaging(computed Europe(53.5%,95%CI,46.0%–60.9%) tomographyormagneticresonanceimaging) Participantsfrom1,294hospitalsregistered thaninEasternEurope(39.5%;95%CI, wasusedtoidentifythesourceofinfection, forthesurvey.Afterexcludingincomplete 33.0%–46.4%)andWesternEurope(43.0%; and3)surgeryforsourcecontrolwas responsesandduplicates(n=271;20.9%), 95%CI,37.6%–48.5%).Sepsis-1wasusedin availableona24/7(i.e.,serviceunlimited 1,023responses(responserate,79.1%)from 24.5%(95%CI,21.9%–27.3%)ofhospitals intime)basis.Datawereanalyzedusing individualhospitalsfrom69countrieswere andmorecommonlyinEasternEurope SPSSsoftware(version26.0;IBM).Only includedinthisconveniencesample. (37.7%;95%CI,31.2%–44.5%).Sepsis-1and questionnaireswithdefinitiveorassignable Hospitalsincludedintheanalyseswere Sepsis-3criteriawereusedtogetherin23.2% answers(e.g.,no/yes,specificcriteriaor mainlyfromWesternEurope(n=335; (95%CI,20.6%–25.9%)ofhospitals.A measures)wereincludedintheanalysis. 32.7%),EasternEurope(n=215;21.0%), smallerproportionofhospitals(6.9%;95% Theresultsarepresentedasnumbersand SouthernEurope(n=185;18.1%),and CI,5.5%–8.7%)usedothercriteriaorhadno proportionswith95%CIs.Thex2testwas NorthernEurope(n=100;9.8%).Asmaller definitionforsepsis.Sepsis-3wasmore usedtocalculatePvalueswithasignificance groupofhospitalsoutsideEuropewasalso frequentlyusedinuniversityhospitals level(a)lowerthan0.05.Becauseofthe included(Figure1andTableE5).Intotal, (51.0%;95%CI,45.7%–56.2%)thanin multiplecomparisons,aBonferroni generalhospitalsconstituted56.5%ofthe generalhospitals(42.0%;95%CI, correctionwasperformed.Uncorrectedand sample(n=578),universityhospitals35.7% 38.0%–46.2%)andmoreofteninhospitals correctedPvaluesarepresentedinthetables. (n=365),andprivatehospitals7.8%(n=80). withmorethan750beds(Table1). Figure1. Participatingcountriesandnumbersofhospitalsinthedifferentregionssampled(seeTableE5fordetailedinformation). 590 American Journal of Respiratory and Critical Care Medicine Volume 211 Number 4 | April 2025 ORIGINAL ARTICLE Table1. UseofSepsis DefinitionsinDifferent Regionsand HospitalSizesand Types AnyOther No.of Sepsis-1and DefinitionorNo Hospitals Sepsis-1Used Sepsis-3Used Sepsis-3Used DefinitionUsed Allhospitals 1,023 24.5%(21.9%–27.3%) 45.4%(42.3%–48.5%) 23.2%(20.6%–25.9%) 6.9%(5.5%–8.7%) Region NorthernEurope 100 18.0%(11.0%–26.9%) 48.0%(37.9%–58.2%) 10.0%(4.9%–17.6%) 24.0%(16.0%–33.6%) EasternEurope 215 37.7%(31.2%–44.5%) 39.5%(33.0%–46.4%) 17.2%(12.4%–22.9%) 5.6%(2.9%–9.5%) SouthernEurope 185 22.7%(16.9%–29.4%) 53.5%(46.0%–60.9%) 20.0%(14.5%–26.5%) 3.8%(1.5%–7.6%) WesternEurope 335 18.2%(14.2%–22.8%) 43.0%(37.6%–48.5%) 33.4%(28.4%–38.8%) 5.4%(3.2%–8.4%) Otherregions 188 26.1%(19.9%–33.0%) 46.8%(39.5%–54.2%) 21.8%(16.1%–28.4%) 5.3%(2.6%–9.6%) Hospitalsize 0–250beds 295 29.8%(24.7%–35.4%) 40.7%(35.0%–46.5%) 24.4%(19.6%–29.7%) 5.1%(2.9%–8.2%) 251–500beds 298 25.8%(21.0%–31.2%) 43.0%(37.3%–48.8%) 22.8%(18.2%–28.0%) 8.4%(5.5%–12.1%) 501–750beds 157 22.3%(16.0%–29.6%) 47.1%(39.1%–55.2%) 22.3%(16.0%–29.6%) 8.3%(4.5%–13.7%) 751–1,000beds 133 17.3%(11.3%–24.8%) 54.1%(45.3%–62.8%) 21.8%(15.1%–29.8%) 6.8%(3.1%–12.5%) .1,000beds 140 20.0%(13.7%–27.6%) 50.0%(41.4%–58.6%) 23.6%(16.8%–31.5%) 6.4%(3.0%–11.9%) Hospitaltype Generalhospitals 578 27.7%(24.1%–31.5%) 42.0%(38.0%–46.2%) 23.0%(19.6%–26.7%) 7.3%(5.3%–9.7%) Universityhospitals 365 19.5%(15.5%–23.9%) 51.0%(45.7%–56.2%) 22.7%(18.5%–27.4%) 6.8%(4.5%–9.9%) Independenthospitals 80 25.0%(16.0%–35.9%) 43.8%(32.7%–55.3%) 26.3%(17.0%–37.3%) 5.0%(1.4%–12.3%) Datainparenthesesare95%CIs.“Sepsis-1”referstothesystemicinflammatoryresponsesyndromecriteriaduetoinfection.“Sepsis-3”refers toneworganfailureasevidencedbyanincreaseinSequentialOrganFailureAssessmentscoreby>2duetoinfection. AdherencetotheSurvivingSepsis differentsizesorbetweengeneral,university, wards.InICUs,bloodpressure(92.3%) CampaignGuideline andprivatehospitals(TablesE10–E12). temperature(91.9%),lactate(89.8%), Recommendations Screeningwasdonedailyin51.0%(95%CI, respiratoryrate(89.4%),andmental SepsisScreening.Standardizedsepsis 46.0%–55.9%)ofwardsand75.8%(95%CI, alterations(89.3%)werethemostcommon screening(seeonlinesupplementfor 71.9%–79.4%)ofICUsandlessfrequentlyor criteriaforsepsis,followedbyheartrate definitions)asameasureforearlysepsis onlyondemandintheremainingwardsand (88.7%)andorgandysfunction(88.5%).See identificationwasusedin54.2%(95%CI, ICUs(TableE13).InEDsandwardswith TableE13fordetailsaboutthecriteriafor 50.6%–57.7%)ofEDs,47.9%(95%CI, standardizedsepsisscreeningpractices,the sepsisscreeningincludingbiomarkers 44.5%–51.3%)ofwards,and61.7%(95% mostcommonscreeningcriteriawere andscores. CI,58.4%–65.0%)ofICUs.Therewere respiratoryrate(EDs,89.8%;wards,85.0%), ThecompletesetoffourSystemic significantdifferencesinsepsisscreening bloodpressure(EDs,88.6%;wards,83.0%), InflammatoryResponseSyndromecriteria betweenregions(P,0.001).Screening temperature(EDs,87.2%;wards,87.2%), wasusedin56.3%ofEDsand63.1%of occurredmorefrequentlyinEDsandwards heartrate(EDs,84.6%;wards,83.5%),and ICUsinhospitalsthatappliedtheSepsis-1 inNorthernEuropethanintherestof mentalalterations(EDs,86.5%;wards, definition.Agreaternumberofhospitals Europe(Figure2).Therewerenostatistically 81.0%).Lactatemeasurementwasusedfor usedareducedsetofSystemicInflammatory significantdifferencesbetweenhospitalsof screeningin77.9%ofEDsand61.8%of ResponseSyndromecriteria.Hospitalsthat Figure2. Screeningforsepsisindifferentregions:proportionsofscreeninginemergencydepartments,onwards,andinICUs.Thebluebars showtheproportionsofscreeninginthedifferentregions.Thegreenlinerepresentsthelevelofscreeninginemergencydepartments,wards, andICUsinallhospitalsthathaveaqualityimprovementinitiative(QII)onaregularbasis.The95%CIsofhospitalswithQIIsaredisplayedas greendottedlines.TheabsolutedifferencesbetweenhospitalswithQIIsandhospitalsineachregionaredisplayedingray(seeFigure5). Scheer, Giamarellos-Bourboulis, Ferrer, et al.: Sepsis Care in Hospitals 591 ORIGINAL ARTICLE usedtheSepsis-3definitionweremorelikely QIIsandSepsisPrograms.Atotalof thesourceofinfectionaroundtheclockin tousethequickSequentialOrganFailure 31.4%ofrespondents(95%CI,28.3%–34.7%) 89.9%(95%CI,87.8%–91.8%)ofhospitals. AssessmentandSequentialOrganFailure hadprogramsavailabletoincreasethequality Theavailabilityofanimagingservice Assessmentscores,particularlywithinthe ofsepsiscare.QIIsacrossthewholehospital withcomputedtomographyormagnetic ICUs(82.5%vs.51.4%inhospitalsthatused (ED,wards,andICUs)existedonaregular resonanceimagingwithnotimelimitations theSepsis-1definition)(seeTableE13).Early basisinonly9.8%(95%CI,7.9%–12.0%)of wassignificantlyhigherinlargerhospitals warningscoressuchastheNewEarly hospitals,withsignificantdifferencesbetween (TableE22).Themicrobiologicaldiagnostic WarningScoreorModifiedEarlyWarning theregions(P,0.001)(Figure4andTable servicewaslimitedintimein89.6%(95%CI, Scorewereusedin31.1%ofEDs,38.2%of E18).HospitalswithQIIshadgreater 87.6%–91.4%)ofthehospitals.Thelimitations wards,and19.6%ofICUs.Atotalof79.6% implementationofsepsisscreeningand concernedalackofthepossibilitytoincubate (95%CI,70.3%–87.1%)ofrespondentsfrom standardizedsepsismanagementinEDs, bloodcultures,identifypathogens,and hospitalsinNorthernEuropestatedthat wards,andICUs.Implementationof communicateresultsoutsidethemain medicalemergencyteams(METs)whohelp antibioticstewardshipandantimicrobial workinghoursorduringweekendsand toidentifycriticallyillpatientsearlywere guidelinesforpatientswithsepsiswerealso holidays.Servicesthatwereunlimitedin implementedintheirhospitals.Inallother morecommon(Figure5).Accordingtothe time,includingbloodcultureincubation, regions,theavailabilityofMETswas respondents,only4.6%(95%CI,3.3%–6.1%) pathogenidentification,andcommunication significantlylower(TableE14).Inhospitals ofhospitalsinvestedextramoneyinsepsis ofresults,werereportedbyonly106of1,023 with0–250beds,METswereavailablein programs(Figure4andTableE25). (10.4%)hospitals. 43.3%(95%CI,37.5%–49.2%),compared PhysiciansandnursesfromICUsweremore SurgicalandInterventionalSource with58.8%(95%CI,49.8%–67.3%)in oftenpartoftheprogramsthanstafffromthe Control.Surgicalserviceforsourcecontrol hospitalswithmorethan1,000beds. EDorwards(FigureE21).Sepsisprevalence thatwasunlimitedintimewasavailablein Universityhospitals(58.6%;95%CI, andmortalityweremonitoredin54.3%(95% 87.0%(95%CI,84.8%–89.0%)ofthe 53.3%–63.8%)hadMETsmoreoftenthan CI,51.0%–57.5%)and45.0%(95%CI, hospitals.Theavailabilitywashighestin generalhospitals(47.5%;95%CI, 41.7%–48.2%)ofallparticipatinghospitals. hospitalsinWesternEurope(95.5%;95%CI, 43.3%–51.6%)(seeTableE14). Sepsisbundlecompliancewasmeasuredin 92.7%–97.5%)andlowestinhospitalsin StandardizedSepsisManagement. 18.1%(95%CI,15.7%–20.7%)ofhospitals, Asia,CentralandSouthAmerica,andAfrica Protocolsforstandardizedsepsis timetoantibiotictherapyin21.1%(95%CI, (71.1%;95%CI,64.1%–77.5%).Inhospitals management(seeonlinesupplementfor 18.5%–23.9%),severityofsepsiscasesin with0–250beds,theavailabilitywaslower definitions)werereportedtobeavailablein 25.0%(95%CI,22.3%–28.0%)andfrequency (79.9%;95%CI,74.9%–84.4%)thanin 57.3%(95%CI,53.7%–60.8%)ofEDs,45.2% ofbloodcultureorderingin47.5%(95% hospitalswithmorethan250beds(range, (95%CI,41.7%–48.6%)ofwards,and70.7% CI,44.2%–50.7%). 88.9%–91.1%).Therewerenodifferences (95%CI,67.5%–73.8%)ofICUs.Therewere betweengeneral,university,andprivate significantdifferencesinstandardizedsepsis InfrastructureforIdentificationofthe hospitals(TableE23).Theproportionof managementinEDsindifferentregions SourceofInfectionandSourceControl hospitalswithservicesforinterventional (Figure3)butnotbetweenhospitalsof ImagingforIdentificationoftheSource sourcecontrol(e.g.,byradiologists)thatwas differentsizes(TablesE15–E17).Theactions andMicrobiologicalDiagnosticService. unlimitedintimewas31.7%(95%CI, inhospitalswithstandardizedsepsis Computedtomographyormagnetic 28.9%–34.7%).Asmallproportionof managementaredisplayedinTable2. resonanceimagingwasavailabletoidentify hospitals(5.3%;95%CI,4.0%–6.8%)hadno Figure3. Standardizedsepsismanagementindifferentregions:proportionsofstandardizedsepsismanagementinemergencydepartments, onwards,andinICUs.Thebrownbarsshowtheproportionsofstandardizedsepsismanagementinthedifferentregions.Thegreenline representsthelevelofstandardizedsepsismanagementinemergencydepartments,wards,andICUsinallhospitalsthathaveaquality improvementinitiative(QII)onaregularbasis.The95%CIsofhospitalswithQIIaredisplayedasgreendottedlines.Theabsolutedifferences betweenhospitalswithQIIsandhospitalsineachregionaredisplayedingray(seeFigure5). 592 American Journal of Respiratory and Critical Care Medicine Volume 211 Number 4 | April 2025 ORIGINAL ARTICLE Table2. Actionsin HospitalswithStandardizedSepsis Management Emergency Action Departments(n=444) Wards(n=374) ICUs(n=589) SurvivingSepsiscampaignbundle Measuringlactatelevel 93.2%(90.5%–95.4%) 81.6%(77.2%–85.4%) 96.4%(94.6%–97.8%) Obtainingbloodculturesbeforeadministration 97.3%(95.3%–98.6%) 97.1%(94.8%–98.5%) 98.0%(96.5%–98.9%) ofantibiotics Administeringbroad-spectrumantibiotics 91.0%(87.9%–93.5%) 93.6%(90.6%–95.8%) 96.8%(95.0%–98.0%) Beginningrapidadministrationofcrystalloid* 91.2%(88.2%–93.7%) 88.8%(85.1%–91.8%) 94.2%(92.0%–96.0%) Applyingvasopressorstomaintain 81.8%(77.8%–85.2%) 65.8%(60.7%–70.6%) 96.9%(95.2%–98.2%) MAP>65mmHg† Organdysfunction Bloodtesting‡ 93.7%(91.0%–95.8%) 91.4%(88.1%–94.1%) 96.9%(95.2%–98.2%) Catheterization/urineoutputmeasurement 72.3%(67.9%–76.4%) 74.3%(69.6%–78.7%) 90.3%(87.6%–92.6%) SOFAscore 55.4%(50.6%–60.1%) 43.3%(38.2%–48.5%) 77.8%(74.2%–81.1%) Identificationofsource Computedtomography 38.1%(33.5%–42.8%) 39.0%(34.1%–44.2%) 50.1%(46.0%–54.2%) Ultrasound 51.4%(46.6%–56.1%) 43.0%(38.0%–48.2%) 57.9%(53.8%–61.9%) ChestX-ray 65.1%(60.5%–69.5%) 59.4%(54.2%–64.4%) 71.1%(67.3%–74.8%) Additionalmicrobiologicalsampling§ 85.4%(81.7%–88.5%) 85.8%(81.9%–89.2%) 90.7%(88.0%–92.9%) Sourcecontrol Initiationofrapidsourcecontrol 57.4%(52.7%–62.1%) 62.8%(57.7%–67.7%) 70.6%(66.8%–74.3%) (surgicalorinterventional) Sourcecontrolwithin1–6h 33.8%(29.4%–38.4%) 29.9%(25.3%–34.9%) 40.2%(36.3%–44.3%) Sourcecontrolwithin12h 12.2%(9.3%–15.6%) 15.5%(12.0%–19.6%) 15.6%(12.8%–18.8%) Sourcecontrolwithin24h 2.5%(1.2%–4.4%) 4.8%(2.9%–7.5%) 3.9%(2.5%–5.8%) Notimeframe 1.6%(0.6%–3.2%) 2.7%(1.3%–4.9%) 2.0%(1.1%–3.5%) Notspecified 7.4%(5.2%–10.3%) 9.9%(7.1%–13.4%) 8.8%(6.7%–11.4%) Monitoring Centralvenouscatheter 33.1%(28.7%–37.7%) 36.9%(32.0%–42.0%) 78.4%(74.9%–81.7%) ScvO 24.8%(20.8%–29.1%) 27.5%(23.1%–32.4%) 53.1%(49.0%–57.2%) 2 Arterialcatheter 30.2%(25.9%–34.7%) 28.3%(23.8%–33.2%) 74.9%(71.2%–78.3%) Passivelegraisingorfluidchallenge 48.2%(43.5%–53.0%) 47.1%(41.9%–52.3%) 65.5%(61.5%–69.4%) Hemodynamicmeasurementjj 28.2%(24.0%–32.6%) 33.2%(28.4%–38.2%) 55.5%(51.4%–59.6%) Antibioticstewardship Regularconsultationswithinfectiousdiseases 29.7%(25.5%–34.2%) 40.1%(35.1%–45.3%) 39.6%(35.6%–43.6%) specialists Procalcitoninguidedantiinfectivetherapy 47.7%(43.0%–52.5%) 52.7%(47.5%–57.8%) 72.7%(68.9%–76.2%) MRSAtesting 19.4%(15.8%–23.4%) 26.5%(22.1%–31.3%) 36.7%(32.8%–40.7%) Definitionofabbreviations:MAP=meanarterialpressure;MRSA=methicillin-resistantStaphylococcusaureus;ScvO =centralvenousO 2 2 saturation;SOFA=SequentialOrganFailureAssessment. Datainparenthesesare95%CIs. *Beginrapidadministrationof30ml/kgofcrystalloidforhypotensionorlactatelevel>4mmol/L. †ApplyvasopressorsifpatientishypotensiveduringorafterfluidresuscitationtomaintainMAP>65mmHg. ‡Byclinicalchemistry:whitebloodcells,coagulation,renalandliverfunction. §Examples:urine,swabs,cerebrospinalfluid. jjCardiacoutput,strokevolume,pulsepressuremeasurement. servicesforsourcecontrolavailable,leading ofrespondents.Gelatin(8.0%;95%CI, usedby79.3%(95%CI,76.5%–81.9%)of topatienttransfers. 6.3%–10.0%),hydroxyethylstarch(2.8%; respondentsasameasuretoguidefluid 95%CI,1.8%–4.1%),anddextran(1.7%; resuscitation.Passivelegraisingorfluid SpecificMeasuresforHemodynamic 95%CI,0.9%–2.7%)werestillusedinsome challengeswereusedforguidance ResuscitationandAntiinfective hospitals.Thereweresignificantdifferences morefrequentlythanhemodynamic Treatment intheuseoffluidsbetweenregions(Figure measurementslikecardiacoutput,stroke Fluids,HemodynamicEvaluation,and E24).Norepinephrine(93.1%;95%CI, volume,orpulsepressurevariation(Table Management.Participantsfromhospitals 91.2%–94.6%)wasbyfarthemostcommon E26).Point-of-carelactatetestingwas withandwithoutstandardizedsepsis first-linevasoactiveagentinICUs(see availablein83.0%(95%CI,80.2%–85.4%) managementreportedthatbalanced TableE25). ofEDs,44.8%(95%CI,41.5%–48.1%)of crystalloidswereusedmorecommonlythan Bloodpressureandheartrateresponse wards,and91.5%(95%CI,89.5%–93.3%)of 0.9%NaClintheirICUsforpatientswith (92.5%;95%CI,90.6%–94.2%)andurine ICUs.Itwasmorecommonlyavailablein sepsis(89.0%[95%CI,86.7%–90.9%]vs. output(92.2%;95%CI,90.2%–93.9%)were EDsandICUsinNorthernandWestern 39.7%[95%CI,36.5%–43.0%]).Albumin themostcommonparametersguidingfluid Europethaninotherregions,buttherewere wasusedby40.8%(95%CI,37.6%–44.1%) resuscitationinICUs.Lactateclearancewas nosignificantdifferencesbetweenhospitals Scheer, Giamarellos-Bourboulis, Ferrer, et al.: Sepsis Care in Hospitals 593 ORIGINAL ARTICLE Figure4. Qualityimprovementinitiativesforsepsisinhospitals(n=859). ofdifferentsizesorgeneralanduniversity lessfrequentlyinwards(52.7%;95%CI, higherinhospitalswithQIIs(Figure5). hospitals(TableE27). 47.5%–57.8%)(Table2). However,only31.4%ofhospitalshad AntimicrobialGuidelinesandAntibiotic anyQIIs,andfewhospitals(9.8%)had Stewardship.Theuseofstandardoperating implementedaregularQIIacrossthewhole proceduresorhospitalguidelinesfor Discussion hospital.TheratewaslowestinWestern antimicrobialtherapyforpatientswith Europe(5%forregulartrainings),and sepsiswasreportedby74.0%(95%CI, Theresultsofthissurveyprovideinsightinto universityhospitalswerenotperforming 71.1%–76.7%)ofhospitalrepresentatives. sepsiscarein1,023hospitalsin69countries. betterthangeneralhospitals. TheratewashigherinNorthernEurope HospitalsintheEuropeanUnionincludedin Arecentreportofdatafromthe (92.8%;95%CI,85.7%–97.0%)andWestern thesurveyhadatotalof388,000acute-care NationalHealthcareSafetyNetworkinthe Europe(89.2%;95%CI,85.4%–92.3%)and beds,whichcorrespondsto23%ofallacute- UnitedStatesrevealedthat,10%ofU.S. lowerinotherregions:SouthernEurope carebedsintheEuropeanUnion.Outsideof hospitalslackedastandardizedscreening (63.9%;95%CI,56.4%–70.9%);Asia,Central Europe,onlyalimitednumberofhospitals process.Furthermore,.70%ofU.S. andSouthAmerica,andAfrica(62.2%;95% wereincludedinthestudy.Resultssuggest hospitalshadestablishedguidelinesorcare CI,54.7%–69.3%);andEasternEurope that,ataEuropeanlevel,weareadistance pathwaysforthemanagementofsepsis,and (59.6%;95%CI,52.6%–66.3%).Therewere awayfromwhatthe“goldengoal”fora sepsisprogramswerereportedin73%of nosignificantdifferencesbetweenhospitals deadlydiseaseshouldbe. U.S.hospitals(24,25). ofdifferentsizesortypes(TableE28). Screeningforsepsishasbeen Inlightofourfindingsandthedata Antibioticstewardshipteamsweremost recommendedininternationalguidelines fromtheUnitedStates,weproposethat oftenimplementedinWesternEurope formorethan10years(22,23).Infact,the participationinQIIsandsepsisprograms (80.4%;95%CI,75.7%–84.5%)and currentinternationalsepsisguidelines shouldberegardedasbestpracticefor NorthernEurope(77.4%;95%CI, highlightscreeningforsepsisandtheuse achievingtheWorldHealthOrganization 67.6%–85.4%).Inthewards,patients ofstandardoperatingproceduresforthe recommendations(26),theSurvivingSepsis withsepsiswereusuallytreatedbythe managementofsepsisasrecommendation campaignguidelines(2),ornational wardclinicalteams(89.6%;95%CI, numberone(2).Nevertheless,respondents recommendationssuchastheNational 87.5%–91.4%),but24.5%(95%CI, statedthatsepsisscreeningwasimplemented InstituteforHealthandCareExcellence 21.8%–27.3%)ofrespondentsstatedthat inonly62%ofICUsoverallandevenless guidelines(27)intheUnitedKingdom. thetreatmentwasregularlysupportedby ofteninEDs(54%)andwards(48%).In BeneficialeffectsofQIIsweredemonstrated infectiousdiseasesspecialists,and18.1% addition,screeningwasoftennotundertaken innumerousstudies(28–35),andthereare (95%CI,15.8%–20.7%)ofparticipants dailyoravailableonlyondemand,resulting alsostudiesshowingthatsuchinitiatives indicatedregularsupportbyantibiotic inpotentiallymissedcasesofsepsis.In canbecosteffective(32,36–38).TheU.S. stewardshipteams(TableE29).Respondents contrast,hospitalswithQIIsreachedsepsis HospitalSepsisProgram(39,40)suggested statedthatadviceonantimicrobialtreatment screeninglevelsof.70%.Thepattern sevencoreelements,includingactionsfor wasavailabletowardcliniciansin83.3% forstandardizedsepsismanagementwas identificationandmanagementbutalsofor (95%CI,80.7%–85.7%)ofhospitalsand similar,withsubstantiallyhigherratesof trackingoutcomesandreporting.Inour 84.3%(95%CI,81.7%–86.7%)ofICUs standardizedmanagementinhospitals study,only54%ofrespondentsconfirmed (TableE30).Toguideantiinfective withQIIs.Implementationofantibiotic thatsepsisprevalencewasmonitoredand management,procalcitoninwasusedwidely stewardshipandhospitalguidelinesfor 45%statedthatsepsismortalitywas inICUs(72.7%;95%CI,68.9%–76.2%)and antimicrobialtherapywerealsosignificantly recorded.Also,thecoreelementof“hospital 594 American Journal of Respiratory and Critical Care Medicine Volume 211 Number 4 | April 2025 ORIGINAL ARTICLE Figure5. Implementationofscreeningandstandardizedmanagement,antibioticstewardship,andantimicrobialguidelinesinhospitalswithand withoutQIIs.Thespiderchartpresentsimplementationofmeasuresasproportions(percentages).ED=emergencydepartment;QII=quality improvementinitiative. leadershipcommitment”thatdemandsthe availabilityisalsoessentialtoidentifythe diagnosticsavailableona24-hourbasis.In provisionofnecessaryfinancialresourceswas sourceofinfectioninatimelyfashionand 90%ofhospitals,bloodculturediagnostics, hardlyfulfilled.Respondentsinourstudy provideearlysourcecontrol(41–44). whichrepresentacriticalcomponentofsepsis indicatedthatfinancialsupportforsepsis Furthermore,imagingandsurgicaland/or treatment,wasnotaccessibleoutsideregular programswasverylowintheirrespective interventionalsourcecontrolareguideline workinghours.Thiscanresultindelaysin hospitals,withonly4.6%ofhospitalsinvesting recommendations(2,26,27,45).Inour theidentificationofpathogens,whichin insepsisprograms.Thefindingsinourstudy study,imagingandsurgicalserviceswere turnmayimpedetheadaptationand areinstarkcontrasttothosefromtheUnited time-limited,especiallyinsmallhospitals(i.e., optimizationofantiinfectivetherapy. States,whereexecutivesponsorswere fewerthan250beds).Inaddition,source Negativeconsequencescaninclude reportedby55%ofhospitalsandsepsiswas controlwasoftennotangoalwithinthefirst unnecessaryorinadequatetreatment, identifiedasapriorityandcommunicatedto 6hoursaftertherecognitionofsepsis, unnecessaryselectionpressure,and staffin72%ofhospitals(24,25). necessitatingpatienttransferinsomecases. developmentofantimicrobialresistanceand Radiologicalimagingandgeneral Theselimitationsmaydelaycareandincrease antimicrobialharm(47). surgeryareincludedinthestandard theriskofmortality(46).Anotherareaof Basedontheseresults,increasedefforts infrastructureofhospitals,buttheir concernwasthelackofmicrobiological areneededtoimprovesepsiscareinhospitals, Scheer, Giamarellos-Bourboulis, Ferrer, et al.: Sepsis Care in Hospitals 595 ORIGINAL ARTICLE including:1)amplifiedimplementationof diagnosticandtherapeuticinfrastructure, BaquerizoVargas,MarcoBarchetti,Anna toolsfortheearlyidentificationofsepsisand andtheimplementationofQIIs.These Barcz,VladislavBardakhchyan,LukasBarnas, 2)implementationoflocaltreatment resultsunderscorethenecessityformore MonicaBaroni,NelsonBarros,JesusEmilio Barrueco-Francioni,JoannaBartczak, protocolsbasedoninternationalguidelines robustandcomprehensivestrategiesto MichelangeloBartolo,OnurBas,HulyaBasar, andlocalecologyandavailabilityofresources. establishandimplementcomprehensive NicolaeBatir,Jan-HinrichBaumert,Oliver measuresforsepsisidentification, Beck,MarcBeckers,MaryBedding,Ovidiu Limitations diagnostics,andevidence-basedtreatment, HoreaBedreag,MartinBeiderlinden,Albertus Beishuizen,MatijaBelavic(cid:3),NayaBellaub(cid:3)ı- Thissurveyhassomelimitationsthatneedto withtheaimofestablishinguniformquality Pallare(cid:3)s,VladislavBelskii,StepaniBendel,Jan beconsideredwheninterpretingtheresults. standards.(cid:1) Bene(cid:1)s,PatrikBenjaminssonNyberg,Johan Mostrespondentsandresponseswerefrom Berkius,JanaBerkova,FlorianBerteau,Alessio Europeanhospitals,andonlyaverysmall Authordisclosuresareavailablewiththe Berttini,SamiaBetout,MartinBier,MihaelaBlaj, numberwerefromAsia,Africa,andCentral textofthisarticleatwww.atsjournals.org. SabineBlaschke-Steinbrecher,AnaBla(cid:3)zquez Abella(cid:3)n,JohnBleasdale,AlexandreBleibtreu, andSouthAmerica.Informationfrom AutaBlessing,DimitrisBliamplias,Constantine hospitalsoutsidetheseregionswasnot Acknowledgments:Theauthorsthankthe Bloch-Infanger,FlorinBobirca,Aleksandr collected.Therefore,theresultsreflectthe scientificboards/committeesfromthe Bobyshkin,ConstantinBodolea,FelixBoenhof, EuropeanSocietyofIntensiveCareMedicine, situationinEurope.Thestudyrepresentsa PavelBoldyrev,LuigiBonavina,MichaelBooke, EuropeanSocietyofAnaesthesiologyand GabriellaBottari,YvonnickBoue(cid:3),Hjalmar conveniencesamplebecauseparticipants IntensiveCare,EuropeanSocietyfor Bouma,SebastianBrandt,GennadyBregman, contributedonavoluntarybasisandmay EmergencyMedicine,EuropeanSocietyof VioletaBriciu,VioletaTincutaBriciuGiuseppe nothavebeenrepresentative.Apotential ClinicalMicrobiologyandInfectiousDiseases Brisinda,NoraBruns,NikolaBrzanov,Serban- StudyGroupforBloodstreamInfections, selectionbiascannotbeexcluded.A IonBubenek,SonjeMarinaBubonja,Ekaterina EndocarditisandSepsis,andIntensiveCare Hawthorneeffectmighthavealsoinfluenced Budankova,ArnoldusBuenen,MichaelBuerke, SocietyUnitedKingdom,whoreviewedthe DabotaBuowari,SaraCajander,Plinio theresults,wherebyindividualsmodifyan studyprotocolandquestionnaire;the Calligaro,AndrewCampbell,CanAktas¸,Ilkin aspectoftheirbehaviorinresponsetobeing endorsingscientificsocieties,theEuropean Cankayalı,ZhannaCansu,Mar(cid:3)ıaLuisaCanto(cid:3)n observed.Itisindependentofwhether SocietyofAnaesthesiologyandIntensiveCare, Bulnes,IacopoCappellini,ValeriaCaramello, EuropeanSocietyofClinicalMicrobiologyand participantsareselectedrandomlyor SilvaCarbajoAzabal,NievesCarbonell, InfectiousDiseasesStudyGroupfor nonrandomly(48).Witheverysurvey,the AntonioCarneiro,AndreaCarsetti,Reinoud BloodstreamInfections,Endocarditisand Cartuyvels,SulamitaCarvalho-Brugger,Jan responsesmaybemorepositiveornegative Sepsis(fromtheEuropeanSocietyofClinical Castan,MiguelCastelo-BrancoSousa,Pedro thaninreality.However,itislikelythat MicrobiologyandInfectiousDiseases), Castro,AdrianaCataldo,FaustoCatena,Lucia manyofthehospitalswhererespondents EuropeanSocietyforEmergencyMedicine, Cattin,MartinaC (cid:1) ehulic(cid:3)S (cid:1) irac,MartinC (cid:1) erma(cid:3)k, EuropeanSocietyofIntensiveCareMedicine, workedhaveatleastabasicinterestinsepsis ChristosChaintoutis,NilanchalChakraborty, EuropeanSocietyofPaediatricandNeonatal andqualityofcare.Giventhat.90%of IntensiveCare,EuropeanShockSociety, A El g e a n t a a C C h h i a rc la o s v i , e C w a ic n z d , a A n th C a i n c a e s k i , o J s o C se(cid:3) ha P lk e i d as ro , respondentswerehospitaldirectors,heads IntensiveCareSocietyUnitedKingdom,and Cidade,TatianaCiomartan,OsmanSezerCirit, ofdepartments,orconsultants,itcanbe InternationalFluidAcademy,whichsupported BertaCistero(cid:3)Roig,CristianCobilinschi,Elif thedisseminationofthesurvey;allparticipants, assumedthattheyhadacomprehensive Colak,CathalCollins,AnnaConen,Guglielmo understandingoftheprocesseswithintheir includingthosewhodidnotconsenttobeing Consales,JorgeAlejandroContrerasJaquez, namedinthecollaboratorslist;andSimone BrandusaCopacianu,LupedelRocioCoronel respectivehospitals.However,itisimportant MancinifromtheGlobalSepsisAlliancefor Chumbi,AnaCorreia,MiguelCortez,Augusto toacknowledgetheinherentlimitations organizingandcoordinatingthesteering CesarCostaFerreira,JohanCourjon,Ben ofnotconductingauditstovalidatethe committeemeetings. Creagh-Brown,OlafL.Cremer,Aniek r s e ig s n p i o fi n c s a e n s t .I d n is l c a r r e g p e a h n o c s ie p s it b a e ls t , w t e h e e n re d m iff a e y re b n e t M Gr e o m up be a r r s e o a f s th f e oll E o u w r s o : p W ea a n fa S a e A p b s d is e C l-E ar ls e a S la tu m d , y C C C (cid:1) r v u o e r m d tk o b o v a v a(cid:3) c ic(cid:3) , h , R , P e S i n o o a t f r i t a a C C C ze u u m e ri v c(cid:3) p a i R s k, - a A F d s a iv t b u o r r j i i e z a v i s o i , c(cid:3) D M ,M ’A ar a c ti r a n k p a o ito, wardsanddepartments.Theintention AlaaAbed,FillipAbedinov,MarinaAbramyan, StephanieD’Incau,IitaDaavittila,Michael KatieAdams,JanEgilAfset,MariiaAgibalova, ofthisstudywastobeexploratory,and Dalager-Pedersen,DarioMarietti,SwarupDas, MuratAipeissov,HalisAkalın,FirdevsAksoy, generalizationwouldnotbeappropriate.The AbhilashDash,MiteshDavda,MassimoDe ZainabAlDuhailib,AbdulrahmanAl-Fares, resultscanonlygiveanimpressionofthe AimanAl-Touny,ShimaaAl-Touny,Adria(cid:4)Albis, Cal,BasDeGroot,MariaDeMarco,Silvia DeRosa,NicolasDeSchryver,BelindaDe statusinthe1,023sampledhospitals.Finally, TatjanaAleksic,AslıAlkan,SevilAlkan,Ghalib Simone,VesnaDegoricija,MikhailDegtyar, weacknowledgethatwedidnotinvestigate Almekhlafi,AlmudenaAlonso-Ojembarrena, WissemDehria,DouweDekker,Christopher adherenceorcompliancewithexisting MustafaAlrabayah,AhmedSubhyAlsheikhly, Delaney,Tu€rkerDemirtakan,SecilDeniz, screeningprograms. JelmerAlsma,HishamAlthobaiti,SabriEngin DominiqueDescamps,KevinDewit,Ken Altıntop,SimgeAltuntas¸,ParticiaAlvarez,Rute Dewitte,VipinDhama,IdaDiGiacinto,Emilio Alves,AliAmanati,LisaAmir,FatmaAmmari, Diaz,JuanJoseDiazDiaz,EvgeniDimitrov, Conclusions DavidAndaluzOjeda,MariaAndersson,Ana EmineKu€braDindar,DanSebastianD^ırzu, Thepresentstudyoffersinsightsintosepsis Andrijevic(cid:3),StefanAngermair,MarianaAnghele, MichaelDolch,RaymondDominicSavio,Laure c re a g re io i n n s h b o u s t p m ita a l i s n a ly cr i o n ss Eu d r iv o e p r e s . e T g h eo e g fi r n a d p i h n i g ca s l F G B e a o r r f n t f o r a e s n d z d o A o A n A u n r s g m z io e(cid:3) k n i s e i t , w a S r i , c ia A z n , b E A e l l n z_ A b na r ie r k o t i a y n o , A , D r S ł j u i u l k la m o li w a A l i a c n t z n h , a a ne, D D D o o vo m rm rs is a k s n y e s , , , K K P a a a ta t v ia r e z l D y D n o o a n s a D t d a z l e , ie l S l r o z a , a m L n a b o u h w r u a sk D D a u o - t F n ta a o , n , J g T i r r o a i m t, suggestthatthereisconsiderableroomfor Arunachala,AbdullahTarikAslan,Theodoros AnnaEfthymiou,AnastasiyaEgorova,Brigitta improvement,particularlyinalargenumber Aslanidis,OjanAssadian,DoretteAssen, Ehrnstro€m,DominikEinwag,AnnaEklund, ofEuropeanhospitals.Thisisespeciallytrue HakanKorkutAtalan,SefikaNurAyar,Gulbin AndreasEkman,HakanEkvall,SamiaElAzab, withregardtotheearlyidentificationand Aygencel,AfzalAzim,AhmadAzmaHaryaty, MohamedElbahnasawy,HussamElqurashi, WannesBaeten,VladimirBagin,Iulia-Cristina HossamElshekhali,MoatazMaherEmara, standardizedmanagementofsepsis,the Bagiu,MirzaAunMuhammadBaig,Uliana LuisEnsen~at,KanatErbolat,GulErdem, availabilityofguidelines,existenceof Balan-Ilevskaia,RuslanBaltaga,Herbert EsmaEryilmaz-Eren,EstherOviedodelAguila, 596 American Journal of Respiratory and Critical Care Medicine Volume 211 Number 4 | April 2025 ORIGINAL ARTICLE SelinEyu€pog(cid:5)lu,FranciscoJoseEzponda Koc(cid:1)(cid:3)ı,KlausKogelmann,JuliaKolbusz,Elina NitishKumarParmar,JeremiePasquier, Inchauspe,BekaEzugbaia,SamiFahoum,Pio Kolho,AidosKonkayev,IrisKoper,Csaba De(cid:3)boraO.PassosPinheiro,PavlaPaterova, Faust,SergayFedorov,Beta^niaFerreira,Ricard Kopitko(cid:3),NikolaosKoronakis,Oksana PatriciaPatricio,MicalPaul,JadrankaPavic(cid:1)ic(cid:3) Ferrer,ValeriaFico,JanFiersen,PierreFillatre, Korshunkova,ZdenekKos,JuditKovacs, S (cid:1) aric(cid:3),MartinaPavletic,RobertPederson,Kurt MathiasFischer,FrancescoFleres,Mirela SergejaKozar,SebastianKra€mer,Markus Pelgrims,JuanPedroPen~alverSanchez, Flonta,SiminAyselFlorescu,FrancoisFontana, Kredel,MichaelKremer,AndriyKrystopchuk, Anto(cid:3)nioManuelPereiradeFigueiredo, LorenaForcelledo,MariaFortofoiu,Carmen MaximKucher,PınarKu€c¸u€kdemirci-Kaya, BohdanaPereviznyk,JoseLuisPe(cid:3)rez- RosaFragaQuintana,IrvingSantiagoFraire VladimirKulabukhov,AnilKumar,Neeraj Ferna(cid:3)ndez,StefanPersson,PaulaPestana, Felix,AlessiaFranceschi,AntonellaFrattari, Kumar,RameshKumar,RajeshKumar,Pavel ChristophPeter,AlinaPetrica,SirakPetros, ChristianFrey,TinaFrolo,ChristinaFu€ller,Rafal Kupka,ErayKurnaz,TatjanaKurucin,Biljana MatthiasPfersdorff,BarbaraPhilips,Dominik Galuszka,LorenzoGamberini,JoaoGamito Kuzmanovska,MarcosJ.Lago,Tobias Pichler,YaroslavPidhirnyi,JuanFrancisco Lopes,JulioCe(cid:3)sarGarciaCasallas,Pablo Lahmer,JaafarLakhssassi,NikolasLambiris, PiedraRubio,AndrzejPihowicz,FJavierPilar- Garc(cid:3)ıa-Olivares,RoxanaGarcia-Salcido, Jean-PhilippeLanoix,RomaricLarcher, Orive,SilvanaPilia,EricPinck,PauloPinheiro, PiyushGarg,AleksandraGavrilovska-Brzanov, AnnmarieLassen,NathalieLayios,IgorLazic, ClaudiaPlachtzik,ChristophPlank,UlrichPlog, GC.Campello,CaterinaGentili,Ivanka KonstantinLebedinskii,AndreiLekmanov, NinaPolze,FranzPonce,MihaiPopescu, Gergova,MicheleGiannini,PatrikGille- AndreyLenkin,JoseLeonGonzalez,Rafael GeorgiPopivanov,OlgaPoplavskaya,Dmitriy Johnson,YvesGillet,GuyGlover,Sanja Leo(cid:3)nLopez,AdamLeoniuk,SergeyLepshin, Popov,PedroPo(cid:3)voa,FlorianPra€tsch,Gabriel Golubic,PauloGomes,GabrielPetreGorecki, DavidLerouge,LeoLicari,MonicaLicker, Preda,AndreasPrengel,DenisProtsenko, VadimGorokhovskiy,UdoGottschaldt,Egor BørgeLillebo,AdamLinder,ParLindgren, MontserratPujolJover,RosarioCristoforo Govoruha,DominicGrande,SergeGrazioli, JohanLindstrom,KirillLipp,OskarLjungquist, Puleo,AnniPulkkinen,AlexeyPyregov,Raihan IoanaGrigoras,EvgenyGrigoryev,Guillaume LarsLjungstro€m,FerranLlopis,CristinaLo(cid:3)pez Rabbani,GabrieleRacanelli,PetarRadnev, Grillet,IoanaMarinaGrintescu,AlexeyGritsan, Viloria,F.XavierLo(cid:3)pez-Altimiras,Ru€digerLott, MonikaRajani,LukaszRak,MarijaRakonjac, HeinrichVolkerGroesdonk,FredrikGrovan, RichardLowsby,JarosławLubon(cid:3)ski,Filippo MartaRamos,AlexandraRamshorn-Zimmer, Matja(cid:1)zGroznik,MatthiasGru€ndling,Caroline Luciani,Garc(cid:3)ıadeGuadiana-RomualdoLuis, Ale(cid:1)sRa(cid:3)ra,PedroRascadoSedes,Haroon Grupp,MarioGuarino,Joern-Tryggve AnitaLukic,MihaelaLupse,NitiLuthra,Lydia Rashid,KrzysztofRatnicki,SebastianRehberg, Guenther,BertrandGuidet,TeresaGuimaraes, Lydia,MariolaMaciaszek,KarelMaelegheer, MartinReichert,KarlReiter,MKRenuka, Na(cid:3)diaGuimara~es,RaphaelGukasjan,Amit SamiMa€enpa€a€,MohamedMagdy,Ata MarcoResta,JoaoMiguelRibeiro,EduardoA. Gupta,BikramGupta,ManishGupta,Gupta Mahmoodpoor,MarceloMaia,AnttiMa€kela€, RibeirodeCastro,NiccoloRiccardi,Elina AjayKumar,MohanGurjar,SedaGuzeldag, PavelMalina,RavikrishnaMamidanna,Kishore Riihioja,MarcoRipa,CarolineRiske,Irina MartonGyenge,MichaelHabenicht,Oliver Mangal,SimoneMancini,Corina-Cecilia Ristescu,AlbaRivera,Ju€rgenRo€del,Fernando Habler,NajahHadi,SebastianHafner,Thomas Manole-Pa(cid:5)livan,AnnaMa˚nsson,Salvatore Rodr(cid:3)ıguezFerna(cid:3)ndez-Reverte,Mar(cid:3)ıaDolores Hahn,RaheelaHanif,AnamariaHarabor, Marchese,LuisaMarchioni,ElisaMarchionni, Rodr(cid:3)ıguezMulero,JanRoesner,CarolinaS MohamedHasaballah,LiudmilaHasak,Natasa SoudaniMarghli,RomanMarisov,Mariusz Romero,UlrichRonellenfitsch,KatyRose, Hasemaki,MohamedHassan,NasserHassan Siemin(cid:3)ski,DemetraMarkopoulou,Alessio SerenaRossi,NikolettaRovina,EsterRovira AbdalradyHassan,JohannaHa€stbacka, Maroccia,AlejandroMartin-Quiros,Modesto La(cid:3)zaro,SnezanaRsovac,HendrikRu€ddel, AndreasHecker,MartinHela(cid:3)n,FrankHendrich, MartinezPillado,AlfredoMartins,Mehdi JuanCarlosRuiz-Rodriguez,HeinerRuschulte, LuciaHerbel,JuanCarlosHerediaCeden~o, Marzouk,EloraMatanovic(cid:3),ElijahMatuvo, IrinaRuslyakova,StefanRusswurm,Laura Mar(cid:3)ıaJulianaHerna(cid:3)ndez-Benito,IvanHerold, AfanasyMatveev,EkaterinaMatveeva,Martin Ryan,ArminSablotzki,ShikhaSachan,Ajit JuanAntonioHidalgoRamos,ManfredHoefler, Mauch,OktawiaMazanowska,AnnaTeresa Sadangi,AmirSaeed,ZrinkaSafaricOremus, NihatMu€jdatHokenek,AleksanderRygh Mazzeo,CarmeloMazzeo,MaurizioMazzoni, ChinmoySahu,IsmaelSaid-Criado,Boris Holten,MichalHolub,ClaudiaHolzbauer, KarimMechergui,DarioMelani,Lisa Sakakushev,SamirSakka,Giuseppe DavidHonan,CristinaHonorato-Cia,Jacobien Mellhammar,AhmadMeraj,AnnaMeuronen, Salamone,NigelSalter,DaryaSalygina,Samir Hoogerwerf,CarlaHopper,JuanHorcajada, EvangeliaMichailidou,StephanieMifsud, Samal,AleksandrSamorodov,Line PetrHubacek,WillemijnBarbaraHuiszoon- MarianaMihaila,JulioMijangos-Mendez, Samuelsson,DorelSandesc,DuttaSanskriti, Brummelhuis,ShihanMahmudHuq,Pınar MalgorzataMikaszewska-Sokolewicz,Ruth SaiSaran,AliSarı,BenjaminSasko,Angela Hu€seyinUlas¸,MiguelIbarra-Estrada,Mercedes Milheiro,GeorgiMinkov,ShaktiBedanta Saviano,EvaSchaden,FredrikSchio€ler, IbarzVillamayor,BushraIbrahim-Baker, MishraIoanRemusMitre,MagdalenaMiulescu, DimitriosSchizas,ChristianSchlottke,Matthias MiroslawaIdzik,FatihIleri,Bugra _ Ilhan, SkuleMo,OnnenMoerer,PabloMonedero, Schmauß,TomSchmitz,PhilippSchu€tz,Martin RosandaIlic,GarbaIliyasu,Aikaterini NicolasMongardon,ElisabethMontel,Eleni Schwandt,MarkusSchwendinger,Chen-June Ioakeimidou,OrestisIoannidis,IonasSimutis, Moraitou,J.MiquelMorales,MalteMorisse, Seak,SaloniSehgal,ArminSeibel,Ronald DanielaIonescu,AhteshamIqbal,AnnaIrga- DiegoMorochoTutillo,PaulaMota,AshrafButt, Seidel,FlorianSeidlitz,JoanaSelada,Gjulshen Staniukiewicz,ArdaIsik,NahemaIssa,Toni SudiptaMukherjee,ApolloMulyanti,AnaMaria Selim,BilalSengu,EvrenS¸entu€rk,Nicolas Ivic(cid:1)ic(cid:3),ArtemIvkin,AnshulJain,VilleJalkanen, Munteanu,TatianaMusaeva,XavierMuschart, Serck,EricaSermijn,LenaSerrander,Aslan JarosławJanc,SlobodanJankovic(cid:3),Henry TomaszMusiuk,BiserkaMustac-Hlebec, Shabanov,BhagyeshShah,VitragShah,Pralay Jansen,HildeJansens,SusannJ.Ja€rhult,Bjo€rn VentsislavMutafchiyski,OlenaMutuka,Simon ShankarGhosh,KonstantinShapovalov,Sanjay Ja€schke,SinghJasvant,YashJaveri,Etienne Nadel,PrashantNasa,TijanaNastasovic, Sharma,AdityaNathShukla,ValeryShvetsov, Javouhey,PragnyaJena,KimJie,Shabbar LukaszNaumiuk,ElenaNeporada,Christian KhalidSiddiqi,TomaszSiegel,Martin Joad,AnnaJones,SiljeBakkenJørgensen, Nickel,AlexanderNicko,BatirNicolai,Jeppe Siegemund,RafaelSierra,MartinSigurdsson, RomainJouffroy,MarijaJovanovski-Srceva, SylvestAngaardNielsen,AxelNierhaus,Ruud AliHSik,AdrianaSilva,AnabelaLeonorSilva KazimirJuricic,MatijaJurjevic(cid:3),Karin Nijman,FilippiaNikolaou,CarlaNisii,Vasileios Ba(cid:3)rtolo,NunoSilva,KoenSimons,TudorDan Kaasjager,MaheenKabir,EbruKacmaz, Nolas,KuidoNomm,MaximNosenko, Simu,MartinaSinai,RituSingh,SergeySinkov, VasileiosKaldis,DominikKallias,Madhusudan GeorgiosNotas,AndreasNowak,Sinead MichalSitina,TomaszSkalec,Katarzyna Kalluraya,MrinalKamal,FundaKarbekAkarca, O’Neill,Du(cid:1)sankaObradovic(cid:3),SimonOelsner, Skawin(cid:3)ska,AntoniaSkotsimara,KittySlieker, IldarKarimov,EleniKarlafti,HeshamKeryakos, EstherOlaleye,AlessandraOliva,RosaOltra, MariaSlo€cker-Barrio,JakubSmiechowicz, ChristianKeuneke,MohdSaifKhan,Almir Ug(cid:5)urO € nal,KresimirOremus,C¸ig(cid:5)demOrhan, DimitrisSmyrniotis,JanuszSokolowski,Torill Khasanov,EkaterinaKhinovker,Sergey DanieleOrso,UlrichOrtler,MichaelOsthoff, SolvaerRosvoll,OrsolyaSolymos,KapilDev € Khomiakov,KihoonKim,SungHyunKim, StefanOstmeier,AlexeyOvezov,NidaOzcan, Soni,ShivLalSoni,MasaSoric,JensSoukup, MikhailKirov,ThomasKiss,Behc¸etKılıc¸,Kirien OsmanCanO € ztu€rk,OsmanO € zu€dog(cid:5)ru, DavidSouthern,SavinoSpadaro,Martin Kjossev,IrisKlaus,OlgaKlementova,Heinrich CatarinaPacheco,JacobPackmohr,Jose(cid:3)- Spa˚ngfors,AlessandraMariaSpinelliMathias Klingler,GerdKlinkmann,HansKnotzer, ArturPaiva,CarloPallotto,IvanaAntonella Sprenger,NamitaSrivastava,StefanStaar,Pascal VladimirKochergin,JaromirKoci,Karol(cid:3)ına Paolucci,RaffaellaPapa,MariusPapurica, Stammet,PatriciaStassen,Go€ranStenlund, Scheer, Giamarellos-Bourboulis, Ferrer, et al.: Sepsis Care in Hospitals 597 ORIGINAL ARTICLE PetrStepanek,MarijaStevic,SanneSteyaert, ShivShankerTripathi,VincenzoFrancesco vonHolten,MagnusvonSeth,AntonijaVrbanic(cid:3) (cid:1) KellyStraka,DitteGryStrange,BirgittStraub, Tripodi,LiubovTsentsiper,ZeynepTure, Sutalo,BramVrijsen,EvangelosVryonis, YuliaStrezh,NinaSulen,SriSunarmiasih, SebastianTuyls,JonasTverring,NirajTyagi, NatalijaVukovic,MartinWagner,Stig ChristinaFjesmeSundby,JonasSunde(cid:3)n- RyhanUddin,MustafaUg(cid:5)uz,ThomasUhlig, Walravens,PetraWegermann,ChristineWeis, Cullberg,MartinSundqvist,JesperSvefors, RoxanaOanaUngurean,SaschaUssat, IngeborgWelters,BenediktWiggli,Eveny ViktorS (cid:1) vigelj,EileenSweeney,SyedShahrul SandraUsugaPerilla,LianaValeanu,Alda Winklaar,StefanP.Wirtz,RafałWo(cid:3)jtowicz, NazSyedShamsuddin,TamasSzakmany, Valenc¸a,SilviaValentini,JuhaValli,Mika PhunsupWongsurakiat,NuriaWorner JanosSzederjesi,HakanTaban,AnneliesTacx, Valtonen,IlseVanCotthem,BeaVandenPoel, Tomasa,RoelieM.Wo€sten-vanAsperen, SilvaTafaj,O € merTaikın,Toma(cid:3)(cid:1)sTajc(cid:1),Mariola MoniqueVanderLugt,BrunoVanHerendael, MagdalenaWujtewicz,ZhaoyangXing, Talalaj,LokmanHekimTanriverdi,DarkoTasic(cid:3), LennekeVanLelyveld-Haas,TomVanSeveren, MichaelYaroustovsky,DincerYildizdas, PolychronisTasioudis,PierreTattevin,Fatih MartijnVanTellingen,StefanieVandervelden, YvonneYoung,IgorZabolotskikh,Ewa Tekin,RecepTekin,StaffanTevell,AndreasR. PhilippeVanhove,MarinaVarela-Duran, Zabul,MariaZach,AleksandraZałustowicz, Thierbach,IngeThoelen,MarkTimmermans, VivianeVeiga,PaulaVera-Artazcoz,Nikolaas KyriakosZaragkoulias,BarbaraZawi(cid:3)slak, EkaterinaTkachenko,ŁukaszTkaczyk,Matti Verbeke,AnilVerma,ThessaVerniest,Isabelle MarisaZenaideRibeiroGomes,Yoann Tolonen,IvanTomasi,DanaTomescu,Tina Verstreken,JiriVesely,PabloVidal,Jean-Louis Zerbib,ElenaZilbert,WolfgangZink, Tomic(cid:3)Mahec(cid:1)ic(cid:3),IbolyaToth,SebastianTranca, Vincent,AntonellaViola,SimonaViola, FrankZoerner,KonstantinZolotukhin,Joanna StefanoTrapassi,NikitaTrembach,Josep FrancescaViscosi,OlegVoennov,Thomas Zorska,NadezhdaZubareva,andMehrun (cid:3) TrenadoAlvarez,MaksimTribulev,FilipTriest, Volk,CarloAlbertoVolta,Rouven-Alexander Zuleika. References 12.ScheerCS.Bestpracticesandchallengesforsepsismanagementin Europe.TheEuropeanSepsisCareSurvey.Integratingsepsis 1.RuddKE,JohnsonSC,AgesaKM,ShackelfordKA,TsoiD,KievlanDR, managementinEurope’sresponsetoglobalhealththreats.Presented etal.Global,regional,andnationalsepsisincidenceandmortality,1990- attheEuropeanSepsisAlliance6thAnnualMeeting.March21,2023, 2017:analysisfortheGlobalBurdenofDiseaseStudy.Lancet2020; Brussels,Belgium. 395:200–211. 13.ScheerCS.PriseenchargedusepsisenEurope:diagnosticetqualite(cid:3). 2.EvansL,RhodesA,AlhazzaniW,AntonelliM,CoopersmithCM,French PresentedatCycledeConferencessurleSepsis.September11, C,etal.Survivingsepsiscampaign:internationalguidelinesfor 2023,Paris,France. managementofsepsisandsepticshock2021.IntensiveCareMed 14.ScheerCS.Qualita€tsindikatorenzumsepsismanagementim 2021;47:1181–1247. EU-La€ndervergleich—qualityindicatorsforsepsismanagementinEU 3.WorldHealthOrganization.WHA70.7resolution:improvingthe countrycomparison.PresentedatWorldSepsisDayBerlin.September prevention,diagnosisandclinicalmanagementofsepsis.Seventieth 12,2023,Berlin,Germany. WorldHealthAssembly2017.Geneva,Switzerland:WHO;2017[posted 15.ScheerCS.Needoftimelymicrobiologicaldiagnosticinsepticpatients. 2017May29;accessed2022Jun1].Availablefrom:https://apps.who. Managementofsepticpatients:timetoimprovetheclinicaland int/gb/ebwha/pdf_files/WHA70/A70_R7-en.pdf. laboratorypathway.Presentedatthe27thInternationalSymposiumon 4.G7HealthMinisters.Communique:G7HealthMinisters2022[posted InfectionsintheCriticallyIllPatient(ISICIP).October5–6,2023, 2022May20;accessed2022Jun1].Availablefrom:https://www. Barcelona,Spain. g7germany.de/resource/blob/974430/2042058/5651daa321517 16.ScheerCS.QualityofsepsiscareinEurope:wherearethegaps?Sepsis b089cdccfaffd1e37a1/2022-05-20-g7-health-ministers-communique- improvementofprocess-of-care.Presentedatthe27thInternational data.pdf. SymposiumonInfectionsintheCriticallyIllPatient(ISICIP).October 5.ScheerCS.TheneedforaEuropeansepsisregistry.Presentedatthe 5–6,2023,Barcelona,Spain. 19thCongressoftheEuropeanShockSociety.November5–6,2021, 17.ScheerCS.Resultsofaninternationalsurvey.PresentedatInternational EuropeanShockSociety. FluidAcademyDay(IFAD).November23–25,2023,Antwerp,Belgium. 6.ScheerCS.Sepsis:theunrecognizedhealthemergency.Aholistic 18.ScheerCS.Screening,treatmentandqualityimprovementforSepsisin approachtoinfectionmanagement.Presentedatthe25thEuropean Europe—resultsfromtheEuropeanSepsisCareSurvey.Presentedat HealthForumGastein:“AMoonshotforaTrueEuropeanHealth theNationalAnaesthesiaandCriticalCareSymposium.2023[accessed Union–IfNotNow,When?”.September26–29,2022,BadHofgastein, 2023Dec2],Zagreb,Croatia. Austria. 19.EysenbachG.Improvingthequalityofwebsurveys:theChecklistfor 7.ScheerCS.ApictureofqualityofcareinEurope,theEuropeanSepsis ReportingResultsofInternetE-Surveys(CHERRIES).JMedInternet CareSurvey,sepsismanagement:anindicatorofqualityofcarein Res2004;6:e34. Europe.PresentedattheEuropeanSepsisAlliance5thAnnualMeeting. 20.SharmaA,MinhDucNT,LuuLamThangT,NamNH,NgSJ,AbbasKS, September20,2022,Brussels,Belgium. etal.Aconsensus-basedChecklistforReportingofSurveyStudies 8.ScheerCS.Preliminaryresultsofaglobalsurveyonsepsisacutecare (CROSS).JGenInternMed2021;36:3179–3187. awareness.Presentedatthe12thHybridInternationalFluidAcademy 21.UnitedNationsStatisticsDivision.UNM49:StandardCountryorArea Day.November26,2022,Brussels,Belgium.AbstractIFAD2022. CodesforStatisticalUse(SeriesM,No.49).NewYork:UnitedNations 9.ScheerCS,FerrerR,MalbrainMLNG,Giamarellos-BourboulisEJ,Linder DepartmentofEconomicandSocialAffairs(DESA);1999.Revision4. A,FilipescuD.Currentpracticeofsepsisprotocolsandbundlesand 22.RhodesA,EvansLE,AlhazzaniW,LevyMM,AntonelliM,FerrerR,etal. furthermeasuresforhemodynamicstabilizationinEuropeanandnon- SurvivingSepsisCampaign:internationalguidelinesformanagementof Europeanemergencydepartments.PresentedatEuroanaesthesia.June sepsisandsepticshock:2016.IntensiveCareMed2017;43:304–377. 3–5,2023,Glasgow,Scotland. 23.DellingerRP,LevyMM,RhodesA,AnnaneD,GerlachH,OpalSM, 10.ScheerCS,LinderA,AnnaneD,ArtigasA,AslanTA,BaltagaR,etal. etal.;SurvivingSepsisCampaignGuidelinesCommitteeincludingthe Qualityimprovementinitiativesforsepsisandrecordingofsepsis PediatricSubgroup.SurvivingSepsisCampaign:international mortalityinhospitalsofdifferentsizes:resultsfromaninternational guidelinesformanagementofseveresepsisandsepticshock:2012. survey.PresentedatESICMLIVES.October21–25,2023,Milan,Italy. CritCareMed2013;41:580–637. 11.ScheerCS,IdelevichEA,AnnaneD,ArtigasA,AslanAT,BaltagaR, 24.DantesRB,KaurH,BouwkampBA,HaassKA,PatelP,DudeckMA, etal.Reportedtimetobloodcultureresultsinhospitalswith24/7 etal.Sepsisprogramactivitiesinacutecarehospitals—National microbiologicalservicecomparedtohospitalswithlimited HealthcareSafetyNetwork,UnitedStates.MMWRMorbMortalWkly microbiologicalservice:resultsfromaninternationalsurveyin870 Rep2023;72:907–911. hospitals.PresentedatECCMID.April15–18,2023,Copenhagen, 25.CentersforDiseaseControlandPrevention.Hospitalsepsis Denmark. managementandpractices:findingsfromthe2023NHSNAnnual 598 American Journal of Respiratory and Critical Care Medicine Volume 211 Number 4 | April 2025",
    "Conclusion": ""
  },
  "meta": {
    "findit_url": "http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC12005017&blobtype=pdf"
  }
}